Clinical Trial: Artemether/Lumefantrine and Vivax Malaria
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Artemether/Lumefantrine in the Treatment of Plasmodium Vivax Malaria in Eastern Sudan
Brief Summary: The cure rate of artemether/lumefantrine in the treatment of vivax malaria.
Detailed Summary:
Sponsor: University of Khartoum
Current Primary Outcome: The cure rate [ Time Frame: 28 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Fever clearance time [ Time Frame: 28 days ]The time for fever clearance
- Parasite clearance time [ Time Frame: 28 days ]The time for the parasite to clear
Original Secondary Outcome: Same as current
Information By: University of Khartoum
Dates:
Date Received: June 17, 2012
Date Started: September 2011
Date Completion:
Last Updated: January 16, 2013
Last Verified: January 2013